Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.65%
SPX
-0.05%
IXIC
+0.13%
FTSE
-1.11%
N225
0.00%
AXJO
0.00%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
Health Care
abbv
Abbvie
NYSE: ABBV
+0.10 (+0.04%)
232.39
USD
At close at Nov 14, 21:33 UTC
Summary
News
Signals
Benchmarks
Financials

Overview

Loading chart...

Key Stats

Market Cap
410.48B
Dividend Yield
0.00%
P/E Ratio
171.89
EPS
2.41
Revenue
56.33B
Avg. Volume
6.27M

Recently from Cashu

publisher logo
Cashu

AbbVie Stock Rises Amid Surge in Market Interest Following Power Inflow Alert

4 days ago
publisher logo
Cashu

AbbVie’s Growth Driven by Strategic Focus on Immunology and Oncology Innovations

11 days ago
publisher logo
Cashu

AbbVie Faces Increased Short Interest Amid Market Skepticism and Competitive Pressures

14 days ago

About

What does ABBV do?
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
Sector
💻 Health Care
IPO
CEO
Employees
55,000
Headquarters
Illinois, USA
Website
http://www.abbvie.com
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.